[Concerning an implantable contraceptive: a memorandum of a WHO meeting].
出版信息
Bull World Health Organ. 1985;63(5):859-68.
Abstract
摘要
相似文献
1
[Concerning an implantable contraceptive: a memorandum of a WHO meeting].
Bull World Health Organ. 1985;63(5):859-68.
2
Facts about an implantable contraceptive: memorandum from a WHO meeting.
Bull World Health Organ. 1985;63(3):485-94.
3
The biological activities of norgestrel and its enantiomers.
Int J Fertil. 1979;24(1):39-43.
4
Contraception.
J Fam Pract. 1991 Aug;33(2):126.
5
New contraceptive causes controversy.
Ohio Med. 1991 Jul;87(7):327-8.
6
Implantable contraception.
Curr Ther Endocrinol Metab. 1997;6:292-300.
7
[Influence of Norplant contraceptive implants on lactation and infant growth].
Rev Chil Obstet Ginecol. 1985;50(5):421-8.
8
Cost-effectiveness of levonorgestrel subdermal implants. Comparison with other contraceptive methods available in the United States.
J Reprod Med. 1994 Oct;39(10):791-8.
9
Choosing contraceptive steroids and doses.
J Reprod Med. 1983 Jan;28(1 Suppl):57-62.
10
Effect of postcoital contraceptive levonorgestrel (Postinor) on endometrial oestradiol binding.
Ther Hung. 1985;33(3):148-51.
本文引用的文献
1
THE USE OF SILICONE RUBBER AS A CARRIER FOR PROLONGED DRUG THERAPY.
J Surg Res. 1964 Mar;4:139-42. doi: 10.1016/s0022-4804(64)80040-8.
2
Subdermal levonorgestrel implants: serum androgens.
Contracept Deliv Syst. 1983 Apr;4(2):127-31.
3
Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rate.
Contraception. 1982 Dec;26(6):567-85. doi: 10.1016/0010-7824(82)90132-9.
4
A five-year clinical trial of levonorgestrel silastic implants (Norplant TM).
Contraception. 1982 May;25(5):447-56. doi: 10.1016/0010-7824(82)90033-6.
5
Plasma levels of levonorgestrel in women during longterm use of norplant.
Contraception. 1981 Feb;23(2):197-209. doi: 10.1016/0010-7824(81)90105-0.
6
Menstrual blood loss with contraceptive subdermal levonorgestrel implants.
Fertil Steril. 1981 Mar;35(3):304-6. doi: 10.1016/s0015-0282(16)45375-6.
7
Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys.
Contraception. 1981 Dec;24(6):673-83. doi: 10.1016/0010-7824(81)90018-4.
8
Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
Contraception. 1984 Nov;30(5):421-30. doi: 10.1016/0010-7824(84)90034-9.
9
Effect of subdermal levonorgestrel contraceptive implants, Norplant, on serum lipids.
Contraception. 1984 Nov;30(5):413-9. doi: 10.1016/0010-7824(84)90033-7.
10
Effect of subdermal levonorgestrel contraceptive implants, Norplant, on liver functions.
Contraception. 1984 Nov;30(5):407-12. doi: 10.1016/0010-7824(84)90032-5.
Zotero 插件